These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38924597)

  • 1. Clinically relevant doses of tiludronate do not affect bone remodelling in pasture-exercised horses.
    Tippen SP; Metzger CE; Sacks SA; Allen MR; Mitchell CF; McNulty MA
    Equine Vet J; 2024 Jun; ():. PubMed ID: 38924597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
    Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
    BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a bone biopsy technique for measuring tiludronate in horses: a preliminary study.
    Delguste C; Doucet M; Gabriel A; Guyonnet J; Lepage OM; Amory H
    Can J Vet Res; 2011 Apr; 75(2):128-33. PubMed ID: 21731184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
    Gough MR; Thibaud D; Smith RK
    Equine Vet J; 2010 Jul; 42(5):381-7. PubMed ID: 20636772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Analysis of the Use of Tiludronate in Equine Practice: Safety on 1804 Horses, Efficacy on 343 Horses.
    Tischmacher A; Wilford S; Allen K; Mitchell RD; Parkin T; Denoix JM
    J Equine Vet Sci; 2022 Aug; 115():104007. PubMed ID: 35577109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiludronate in horses: A field population study.
    Popot MA; Jacobs M; Garcia P; Loup B; Guyonnet J; Toutain PL; Bailly-Chouriberry L; Bonnaire Y
    Equine Vet J; 2018 Jul; 50(4):488-492. PubMed ID: 29194746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and residence time of bisphosphonates in bone of horses.
    Knych HK; Janes J; Kennedy L; McKemie DS; Arthur RM; Samol MA; Uzal FA; Scollay M
    J Vet Diagn Invest; 2022 Jan; 34(1):23-27. PubMed ID: 34918585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
    Schoonover MJ; Whitfield CT; Young JM; Sippel KM; Payton ME
    Am J Vet Res; 2018 Dec; 79(12):1313-1320. PubMed ID: 30457899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of tiludronate in horses after long-term immobilization.
    Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
    Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
    Whitfield CT; Schoonover MJ; Holbrook TC; Payton ME; Sippel KM
    Am J Vet Res; 2016 Feb; 77(2):167-73. PubMed ID: 27027711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses.
    Knych HK; Finno CJ; Katzman S; Ryan D; McKemie DS; Kass PH; Arthur RM
    Equine Vet J; 2023 Jul; 55(4):696-706. PubMed ID: 35871470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tuber coxae bone biopsy in the standing horse.
    Mitchell CF; Richbourg HA; Goupil BA; Gillett AN; McNulty MA
    Vet Surg; 2017 Apr; 46(3):396-402. PubMed ID: 28112812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial.
    Denoix JM; Thibaud D; Riccio B
    Equine Vet J; 2003 Jun; 35(4):407-13. PubMed ID: 12880010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses.
    Delling U; Lindner K; Ribitsch I; Jülke H; Brehm W
    Can J Vet Res; 2012 Jan; 76(1):52-6. PubMed ID: 22754095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate effects in rat unloaded hindlimb bone loss model: three-dimensional microcomputed tomographic, histomorphometric, and densitometric analyses.
    Barou O; Lafage-Proust MH; Martel C; Thomas T; Tirode F; Laroche N; Barbier A; Alexandre C; Vico L
    J Pharmacol Exp Ther; 1999 Oct; 291(1):321-8. PubMed ID: 10490920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column.
    Coudry V; Thibaud D; Riccio B; Audigié F; Didierlaurent D; Denoix JM
    Am J Vet Res; 2007 Mar; 68(3):329-37. PubMed ID: 17331024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous tiludronate disodium administration on the radiographic progression of osteoarthritis of the fetlock joint in Standardbred racehorses.
    Bertuglia A; Basano I; Pagliara E; Bottegaro NB; Spinella G; Bullone M
    J Am Vet Med Assoc; 2021 Sep; 259(6):651-661. PubMed ID: 34448617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clodronate improves lameness in horses without changing bone turnover markers.
    Mitchell A; Wright G; Sampson SN; Martin M; Cummings K; Gaddy D; Watts AE
    Equine Vet J; 2019 May; 51(3):356-363. PubMed ID: 30153345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low and high dose intraarticular tiludronate on synovial fluid and clinical variables in healthy horses-a preliminary investigation.
    Duesterdieck-Zellmer KF; Moneta L; Ott JF; Larson MK; Gorman EM; Hunter B; Löhr CV; Payton ME; Morré JT; Maier CS
    PeerJ; 2014; 2():e534. PubMed ID: 25237596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clodronate disodium does not produce measurable effects on bone metabolism in an exercising, juvenile, large animal model.
    Vergara-Hernandez FB; Nielsen BD; Popovich JM; Panek CL; Logan AA; Robison CI; Ehrhardt RA; Johnson TN; Chargo NJ; Welsh TH; Bradbery AN; Leatherwood JL; Colbath AC
    PLoS One; 2024; 19(4):e0300360. PubMed ID: 38626145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.